These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 386327)

  • 1. Steroid treatment for routine immunosuppression in cadaver renal transplantation. A survey of hospitals.
    Kumar P; Leech SH; Gonzalez FM; Kodlin D
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():90-2. PubMed ID: 386327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.
    Burleson RL; Scruggs BF; Brennan A
    Clin Nephrol; 1978 Sep; 10(3):87-9. PubMed ID: 359210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of rejection on graft survival after renal transplantation.
    Lytton B; Finkelstein FO; Schiff M; Black HR
    Trans Am Assoc Genitourin Surg; 1975; 67():99-102. PubMed ID: 788307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous bolus dosages of methylprednisolone and local radiation on renal allograft rejection and patient mortality.
    Nakajima N; Sreepada Rao TK; Sakai A; Butt KH; Kountz SL
    Surg Gynecol Obstet; 1977 Jan; 144(1):63-6. PubMed ID: 318773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
    Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C
    Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticosteroids in renal transplantation. II. Impact of high- versus low-dose postoperative methylprednisolone administration on graft survival and on the frequency and type of complications.
    Häyry P; Ahonen J; Kock B; Eklund B; Kauste A; Koskimies S; von Willebrand E
    Scand J Immunol; 1984 Mar; 19(3):211-8. PubMed ID: 6369524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
    Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
    [No Abstract]   [Full Text] [Related]  

  • 14. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of methylprednisolone and prednisone as immunosuppressive agents in clinical renal transplantation.
    Burleson RL; Marbarger PD; Jermanovich N; Brennan AM; Scruggs BF
    Transplant Proc; 1981 Mar; 13(1 Pt 1):339-43. PubMed ID: 7022849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose OKT3 for cadaveric renal transplantation.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
    [No Abstract]   [Full Text] [Related]  

  • 18. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract]   [Full Text] [Related]  

  • 20. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.